Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.

doi:10.2165/11310960-000000000-00000

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.

CNS drugs - 1 Feb 2010

Santoro Aurelia, Siviero Paola, Minicuci Nadia, Bellavista Elena, Mishto Michele, Olivieri Fabiola, Marchegiani Francesca, Chiamenti Andrea Maria, Benussi Luisa, Ghidoni Roberta, Nacmias Benedetta, Bagnoli Silvia, Ginestroni Andrea, Scarpino Osvaldo, Feraco Emidio, Gianni Walter, Cruciani Guido, Paganelli Roberto, Di Iorio Angelo, Scognamiglio Mario, Grimaldi Luigi Maria Edoardo, Gabelli Carlo, Sorbi Sandro, Binetti Giuliano, Crepaldi Gaetano, Franceschi Claudio

Abstract excerpt

Acetylcholinesterase inhibitors (AChEIs) have been used to improve cognitive status and disability in patients with mild to moderate Alzheimer's disease (AD). However, while the efficacy of AChEIs (i.e. how they act in randomized controlled trials) in this setting is widely accepted, their effectiveness (i.e. how they behave in the real world) remains controversial. To compare the effects of three AChEIs,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activities of Daily Living

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholinesterase Inhibitors

Share to Cognition

Share to Indans

Share to Italy

Share to Outcome Assessment, Health Care

Share to Piperidines

Share to Psychiatric Status Rating Scales

Source

Open in PubMed

Identifiers

PMID: 20088621
DOI: 10.2165/11310960-000000000-00000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.PMID 20088621Read ↗

BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.Semantic proximity Read ↗

Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease.Semantic proximity Read ↗

Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.Semantic proximity Read ↗

Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-world DataSemantic proximity Read ↗

Effect of Acetylcholinesterase Inhibitors on the Cognitive Impairments in Transgenic Drosophila Model of Alzheimer’s DiseaseSemantic proximity Read ↗

Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.Semantic proximity Read ↗

Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.Semantic proximity Read ↗

APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.Semantic proximity Read ↗

Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.Semantic proximity Read ↗

Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients.Semantic proximity Read ↗

Replication Study to Confirm the Role of CYP2D6 Polymorphism rs1080985 on Donepezil Efficacy in Alzheimer's Disease PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.